Showing 1 - 2 results of 2 for search 'J. Landman-Parker', query time: 0.02s Refine Results
  1. 1
    S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN-LABEL, KEYNOTE-667 STUDY

    S204: PEMBROLIZUMAB IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED CLASSICAL HODGKIN LYMPHOMA WITH SLOW EARLY RESPONSE TO FRONTLINE CHEMOTHERAPY: THE PHASE 2, OPEN-LABEL, KEYNOT... by L. Vinti, S. Daw, C. Sabado Alvarez, F. Fagioli, A. Beishuizen, G. Michel, M. L. Moleti, M. Cepelova, A. Thorwarth, C. Rigaud, D. Plaza Lopez de Sabando, J. Landman Parker, Y. Zhu, P. Pillai, A. Nahar, C. Mauz-Koerholz

    Published 2022-06-01
    Get full text
    Article
  2. 2
    Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders

    Immune checkpoint inhibitors in MITF family translocation renal cell carcinomas and genetic correlates of exceptional responders by A. Boilève, M. I. Carlo, P. Barthélémy, S. Oudard, D. Borchiellini, M. H. Voss, S. George, C. Chevreau, J. Landman-Parker, M-D Tabone, D. D. Chism, A. Amin, M. A. Bilen, D. Bosse, A. Coulomb-L’hermine, Xiaoping Su, T. K. Choueiri, Nizar M. Tannir, Gabriel G. Malouf

    Published 2018-12-01
    Get full text
    Article

Search Tools: